Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for the treatment of synucleinopathies, which include DLB and Parkinson's disease; and CT2074 to treat dry AMD. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York.
Over the last 12 months, insiders at Cognition Therapeutics, Inc. have bought $9,975 and sold $0 worth of Cognition Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Cognition Therapeutics, Inc. have bought $3.75M and sold $4,818 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ricciardi Lisa (CEO & President) — $19,950.
The last purchase of 5,700 shares for transaction amount of $9,975 was made by Ricciardi Lisa (CEO & President) on 2024‑03‑14.
2024-03-14 | Ricciardi Lisa | CEO & President | 5,700 0.0172% | $1.75 | $9,975 | +8.94% | ||
2022-11-29 | RICHSTONE ELLEN B | director | 10,000 0.0453% | $2.65 | $26,550 | -29.84% | ||
2022-11-28 | Kreis Leslie W. | director | 16,064 0.0706% | $2.65 | $42,565 | -31.76% | ||
2022-11-28 | Fletcher Aaron G.L. | director | 16,064 0.0706% | $2.65 | $42,565 | -31.76% | ||
2022-11-16 | Kreis Leslie W. | director | 71,000 0.3069% | $1.40 | $99,400 | +27.37% | ||
2022-11-16 | Fletcher Aaron G.L. | director | 71,000 0.3069% | $1.40 | $99,400 | +27.37% | ||
2022-11-15 | Kreis Leslie W. | director | 1.5M 5.2511% | $1.20 | $1.8M | +20.34% | ||
2022-11-15 | Fletcher Aaron G.L. | director | 1.5M 5.2511% | $1.20 | $1.8M | +20.34% | ||
2022-11-15 | Wallace Peggy | director | 12,500 0.0438% | $1.20 | $15,000 | +20.34% | ||
2022-11-15 | Ricciardi Lisa | CEO & President | 12,000 0.0455% | $1.30 | $15,600 | +20.34% | ||
2021-10-13 | Sale | Ogden CAP Associates, LLC | 10 percent owner | 74.05 0.0014% | $12.00 | $889 | -76.39% | |
2021-10-13 | Sale | Golden Seeds Cognition Therapeutics LLC | 10 percent owner | 33.09 0.0006% | $12.00 | $397 | -76.39% | |
2021-10-13 | Sale | Breedlove Mark H. | director | 23.48 0.0004% | $12.00 | $282 | -76.39% | |
2021-10-13 | Sale | Fletcher Aaron G.L. | director | 180.56 0.0034% | $12.00 | $2,167 | -76.39% | |
2021-10-13 | Sale | BIOS Memory SPV I, LP | 10 percent owner | 90.28 0.0017% | $12.00 | $1,083 | -76.39% | |
2021-10-13 | Fletcher Aaron G.L. | director | 380,000 7.2005% | $12.00 | $4.56M | -76.39% | ||
2021-10-13 | BIOS Memory SPV I, LP | 10 percent owner | 190,000 3.6003% | $12.00 | $2.28M | -76.39% | ||
2021-10-13 | Ricciardi Lisa | CEO & President | 25,000 0.4737% | $12.00 | $300,000 | -76.39% | ||
2021-10-13 | O'Brien James Michael | Chief Financial Officer | 10,000 0.1895% | $12.00 | $120,000 | -76.39% | ||
2021-10-13 | Wallace Peggy | director | 3,000 0.0568% | $12.00 | $36,000 | -76.39% |
Ricciardi Lisa | CEO & President | 291345 0.0763% | $1.70 | 3 | 0 | <0.0001% |
Ogden CAP Associates, LLC | 10 percent owner | 2210377 6.8812% | $1.70 | 0 | 1 | |
Golden Seeds Cognition Therapeutics LLC | 10 percent owner | 2177985 6.7804% | $1.70 | 0 | 1 | |
Kreis Leslie W. | director | 2021906 6.2945% | $1.70 | 3 | 0 | +5.32% |
Fletcher Aaron G.L. | director | 2021906 6.2945% | $1.70 | 4 | 1 | <0.0001% |
BIOS Memory SPV I, LP | 10 percent owner | 899905 2.8015% | $1.70 | 1 | 1 | <0.0001% |
Breedlove Mark H. | director | 404439 1.2591% | $1.70 | 0 | 1 | |
Wallace Peggy | director | 37961 0.1182% | $1.70 | 2 | 0 | <0.0001% |
RICHSTONE ELLEN B | director | 10000 0.0311% | $1.70 | 1 | 0 | <0.0001% |
O'Brien James Michael | Chief Financial Officer | 5000 0.0156% | $1.70 | 1 | 0 | <0.0001% |
Aigh Capital Management Llc | $3.45M | 4.74 | 1.9M | -6.94% | -$257,675.61 | 2.05 | |
The Vanguard Group | $1.68M | 2.3 | 921,680 | +27.73% | +$364,229.41 | <0.0001 | |
Awm Investment Company Inc | $1.18M | 1.62 | 650,000 | New | +$1.18M | 0.18 | |
Alyeska Investment Group L P | $910,000.00 | 1.25 | 500,000 | New | +$910,000.00 | 0.01 | |
Timelo Investment Management Inc. | $874,839.00 | 1.2 | 480,681 | New | +$874,839.00 | 1.6 | |
Corsair Capital Management LP | $518,700.00 | 0.71 | 285,000 | New | +$518,700.00 | 0.15 | |
Hohimer Wealth Management Llc | $409,500.00 | 0.56 | 225,000 | New | +$409,500.00 | 0.1 | |
Carlson Capital, L.P. | $389,471.00 | 0.53 | 213,995 | -10.09% | -$43,689.11 | 0.04 | |
American Financial Group | $373,000.00 | 0.51 | 205,000 | 0% | +$0 | 0.16 | |
Kestra Advisory Services LLC | $362,970.00 | 0.5 | 199,434 | -9.11% | -$36,400.01 | <0.01 | |
Geode Capital Management | $337,140.00 | 0.46 | 185,196 | +5.95% | +$18,929.04 | <0.0001 | |
Cm Management Llc | $318,500.00 | 0.44 | 175,000 | New | +$318,500.00 | 0.02 | |
Sigma Planning Corp | $290,181.00 | 0.4 | 159,440 | +458.46% | +$238,219.96 | 0.01 | |
Renaissance Technologies | $283,000.00 | 0.39 | 155,700 | +1,197.5% | +$261,188.83 | <0.0001 | |
Bridgeway Capital Management | $139,594.00 | 0.19 | 76,700 | -15.9% | -$26,390.00 | <0.01 | |
Mercer Global Advisors Inc Adv | $131,000.00 | 0.18 | 71,901 | -45.09% | -$107,586.13 | <0.0001 | |
BlackRock | $101,592.00 | 0.14 | 55,820 | +0.38% | +$384.02 | <0.0001 | |
Texas Capital Bank Wealth Management Services Inc | $100,819.00 | 0.14 | 55,395 | 0% | +$0 | 0.01 | |
FCA Corp | $93,677.00 | 0.13 | 51,471 | 0% | +$0 | 0.03 | |
State Street | $92,365.00 | 0.13 | 50,750 | 0% | +$0 | <0.0001 | |
Circle Wealth Management, LLC | $88,893.00 | 0.12 | 48,842 | New | +$88,893.00 | <0.01 | |
Northern Trust | $86,423.00 | 0.12 | 47,485 | +54.56% | +$30,508.77 | <0.0001 | |
Levin Capital Strategies | $54,600.00 | 0.08 | 30,000 | New | +$54,600.00 | 0.01 | |
Tocqueville Asset Management | $47,320.00 | 0.07 | 26,000 | New | +$47,320.00 | <0.01 | |
NORTHEAST FINANCIAL CONSULTANTS, INC | $44,590.00 | 0.06 | 24,500 | 0% | +$0 | <0.01 | |
Bangor Savings Bank | $43,715.00 | 0.06 | 24,019 | 0% | +$0 | <0.01 | |
Hightower Advisors | $41,000.00 | 0.06 | 22,962 | -30.34% | -$17,855.59 | <0.0001 | |
Baird Financial Group Inc | $40,755.00 | 0.06 | 22,393 | 0% | +$0 | <0.0001 | |
Gratus Capital | $33,532.00 | 0.05 | 18,424 | New | +$33,532.00 | <0.01 | |
Acadian Asset Management | $23,000.00 | 0.03 | 12,691 | New | +$23,000.00 | <0.0001 | |
Charles Schwab | $21,776.00 | 0.03 | 11,965 | 0% | +$0 | <0.0001 | |
Smith Anglin Financial Llc | $21,840.00 | 0.03 | 12,000 | 0% | +$0 | <0.01 | |
Raymond James Associates | $18,200.00 | 0.03 | 10,000 | New | +$18,200.00 | <0.0001 | |
Tower Research Capital | $11,681.00 | 0.02 | 6,418 | +31.87% | +$2,822.88 | <0.0001 | |
Northwestern Mutual Wealth Management Co | $10,678.00 | 0.02 | 5,867 | 0% | +$0 | <0.0001 | |
Bank of America | $9,100.00 | 0.01 | 5,000 | -0.28% | -$25.48 | <0.0001 | |
Morgan Stanley | $5,460.00 | 0.01 | 3,000 | -86.28% | -$34,341.58 | <0.0001 | |
Bray Capital Advisors | $4,095.00 | 0.01 | 2,250 | 0% | +$0 | <0.01 | |
Sandy Spring Bank | $3,640.00 | 0.01 | 2,000 | New | +$3,640.00 | <0.0001 | |
Qube Research & Technologies | $3,860.00 | 0.01 | 2,121 | New | +$3,860.00 | <0.0001 | |
Advisor Group Holdings Inc | $2,120.00 | <0.01 | 1,165 | New | +$2,120.00 | <0.0001 | |
Royal Bank of Canada | $0 | <0.01 | 4 | -97.99% | -$0 | <0.0001 | |
Fidelity Investments | $2.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
JPMorgan Chase | $127.00 | <0.01 | 70 | +100% | +$63.50 | <0.0001 | |
Wells Fargo | $266.00 | <0.01 | 146 | +7.35% | +$18.22 | <0.0001 |